Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Antares Vision Group has introduced a revolutionary digital healthcare solution aimed at streamlining the logistics of drugs and medical devices, effectively minimizing or entirely removing tasks that do not add value for patients while fostering a new standard of operational efficiency for healthcare providers. This innovative Medication Management Platform is designed to eliminate unnecessary activities, thereby enabling hospital systems to better allocate the time of medical and nursing staff, allowing them to concentrate more on patient care and safety. Furthermore, the platform ensures complete traceability of the movement of medicines and medical devices, integrating automation technologies that enhance both efficiency and operational excellence in healthcare settings. By merging automation and traceability, the platform facilitates improved management of inventory and reordering processes at both central and peripheral locations, ultimately reducing material waste caused by expiration. This comprehensive approach not only supports healthcare providers in optimizing their resources but also promotes a more effective and patient-centered care environment.

Description

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Antares Vision Group

Country

Italy

Website

www.antaresvisiongroup.com/lifescience/medication-management-platform/

Vendor Details

Company Name

Omda

Founded

1999

Country

Norway

Website

omda.com/solutions/medication-management/omda-cytodose/

Product Features

Alternatives

Alternatives

oneMAR Reviews

oneMAR

Catalyst Healthcare